Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single-arm, Open-label Clinical Study of SZ011 in the Treatment of Advanced Triple Negative Breast Cancer

NCT05686720 is registered in ClinicalTrials.gov with First Affiliated Hospital of Shantou University Medical College as lead sponsor.

NCT NCT05686720
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05686720 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single-arm, Open-label Clinical Study of SZ011 in the Treatment of Advanced Triple Negative Breast Cancer
Lead sponsor
First Affiliated Hospital of Shantou University Medical College
Phase
Phase 1
Overall status
Unknown status
Start date
February 1, 2023
Completion date
June 1, 2024
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced triple negative breast cancer